search icon

    Market Snapshot

    • S&P Futures

      4,122.5

    • Dow Futures

      32,758

    • Nasdaq Futures

      12,989.5

    blog search icon

    Marker Therapeutics, Inc.

    (NASDAQ:MRKR)

    $0.51

    -$0.05

    -9.25%

    Marker Therapeutics, Inc. Chart

    MRKR Stock Price Today

    Marker Therapeutics, Inc. (MRKR) stock declined over -9.25% intraday to trade at $0.51 a share on NASDAQ. The stock opened with a loss of -15.00% at $0.465 and touched an intraday high of $0.538, falling -5.56% against the last close of $0.54. The stock went to a low of $0.415 during the session.

    Stock Snapshot

    $0.54

    Prev. Close

    28.72 Million

    Market Cap

    $0.415

    Day Low

    $0.465

    Open

    83.11 Million

    Number of Shares

    $0.538

    Day High

    -

    P/E ratio

    -0.52

    EPS (TTM)

    0.34

    Cash Flow per Share

    1.68

    Free Float in %

    0.63

    Book Value

    160,112

    Volume

    Marker Therapeutics, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-08-08$0.465$0.538$0.415$0.5387,315,737
    2022-08-05$0.6$0.66$0.49$0.5473,778,500
    2022-08-04$0.32$0.35$0.32$0.338,322,700
    2022-08-03$0.32$0.34$0.31$0.33208,700
    2022-08-02$0.32$0.32$0.3$0.31408,400
    2022-08-01$0.32$0.32$0.3$0.3185,800
    2022-07-29$0.33$0.36$0.3$0.32112,700
    2022-07-28$0.33$0.36$0.32$0.33126,400
    2022-07-27$0.32$0.34$0.32$0.3263,000
    2022-07-26$0.34$0.34$0.32$0.32104,300

    Contact Details

    3200 Southwest Freeway
    Suite 2500
    Houston, TX 77027
    United States

    Webiste:MRKR

    713 400 6400

    Company Information

    Employees-

    Beta1.27

    Sales or Revenue2.21 Million

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens and kill tumor cells expressing tumor-associated antigens. The company's MultiTAA-specific T cell therapies include autologous T cells for the treatment of lymphoma, and various solid tumors; allogeneic T cells for the treatment of acute myeloid leukemia and acute lymphoblastic leukemia; and off-the-shelf products in various indications. It is also developing TPIV100/110, a peptide-based immunotherapeutic vaccines for the treatment of breast and ovarian cancer cells; and TPIV200, which is in Phase 2 clinical trial for the treatment of breast and ovarian cancers. The company was founded in 1999 and is headquartered in Houston, Texas.

    Frequently Asked Questions

    icon

    What is the current Marker Therapeutics, Inc. (MRKR) stock price?

    Marker Therapeutics, Inc. (NASDAQ: MRKR) stock price is $0.51 as of the last check on Monday, August 8. During the trading session, MRKR stock reached the peak price of $0.538 while $0.415 was the lowest point it dropped to.

    icon

    MRKR's industry and sector of operation?

    The NASDAQ listed MRKR is part of Biotechnology industry that operates in the broader Health Care sector. Marker Therapeutics, Inc. , a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States.

    icon

    Who are the executives of MRKR?

    Mr. Peter L. Hoang MBA
    Pres, CEO & Director
    Mr. Anthony H. Kim
    Chief Financial Officer
    Dr. Mythili Koneru M.D., Ph.D.
    Chief Medical Officer
    Dr. Juan F. Vera M.D.
    Co-Founder, COO, Chief Scientific Officer & Director

    icon

    What is the MRKR stock price today?

    MRKR stock traded closed the last session at $0.538, which is -$0.052000000000000046 or -9.252669039145916% lower than its previous close of $0.54. MRKR's current trading price is 124.8% lower than its 52-week high of $2.13 where as its distance from 52-week low of 0.25% is -73.62%.

    icon

    How many employees does MRKR have?

    Number of MRKR employees currently stands at -. MRKR operates from 3200 Southwest Freeway, Suite 2500, Houston, TX 77027, United States.

    icon

    Link for MRKR official website?

    Official Webiste of $MRKR is: https://www.markertherapeutics.com

    icon

    How do I contact MRKR?

    MRKR could be contacted at MRKR operates from 3200 Southwest Freeway, Suite 2500, Houston, TX 77027, United States, or at phone #713 400 6400 and can also be accessed through its website.

    icon

    How many shares of MRKR are traded daily?

    MRKR stock volume for the day was 160,112 shares while in the previous session number of MRKR shares traded was 7,315,737 . The average number of MRKR shares traded daily for last 3 months was 1.55 Million.

    icon

    How much did MRKR change today?

    The percentage change in MRKR stock occurred in the recent session was -9.252669039145916% while the dollar amount for the price change in MRKR stock was -$0.052000000000000046.

    icon

    What price range MRKR stock been trading in?

    In the recent session, the day high for MRKR stock was $0.538 while the low for MRKR stock touched on the day was $0.415.

    icon

    What is the market cap of MRKR currently?

    The market value of MRKR currently stands at 28.72 Million with its latest stock price at $0.51 and 83.11 Million of its shares outstanding.